高德紅外(002414.SZ):中標武漢高德紅外股份有限公司某型號產品
格隆匯12月2日丨高德紅外(002414.SZ)公佈,公司於近日收到《某型號競標項目》中標通知函,中標單位及產品:武漢高德紅外股份有限公司、某型號產品。
根據《某型號項目競標擇優細則》要求,經過對該型號產品在研製方案、技術指標滿足程度、科研生產能力等五項內容的比測中,公司以評分第一的優異結果勝出。本次中標的型號產品為某完整裝備系統核心配套產品,根據型號產品批產特性,該重點型號產品將在未來年度對公司業績增長產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.